187 related articles for article (PubMed ID: 15098249)
1. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
Islam S; West AM; Saboorian MH; Ashfaq R
Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
[TBL] [Abstract][Full Text] [Related]
2. Restoring satisfactory status in ThinPrep Pap test specimens with too few squamous cells and containing microscopic red blood cells.
Pang Y; Smola B; Pu RT; Michael CW
Diagn Cytopathol; 2008 Oct; 36(10):696-700. PubMed ID: 18773435
[TBL] [Abstract][Full Text] [Related]
3. A simple method to determine the need for glacial acetic acid treatment of bloody ThinPrep Pap tests before slide processing.
Rowe LR; Bentz JS
Diagn Cytopathol; 2004 Nov; 31(5):321-5. PubMed ID: 15468133
[TBL] [Abstract][Full Text] [Related]
4. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
5. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
6. The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?
Bentz JS; Rowe LR; Gopez EV; Marshall CJ
Am J Clin Pathol; 2002 Mar; 117(3):457-63. PubMed ID: 11888086
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: effect on Hybrid Capture II human papillomavirus testing and clinical follow-up.
Agoff SN; Dean T; Nixon BK; Ingalls-Severn K; Rinker L; Grieco VS
Am J Clin Pathol; 2002 Nov; 118(5):727-32. PubMed ID: 12428793
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ThinPrep preparations with conventional cervicovaginal smears. Practical considerations.
Bur M; Knowles K; Pekow P; Corral O; Donovan J
Acta Cytol; 1995; 39(4):631-42. PubMed ID: 7631535
[TBL] [Abstract][Full Text] [Related]
9. Impact of the new Bethesda System 2001 on specimen adequacy of conventional cervicovaginal smears.
Fidda N; Miron J; Rodgers WH; Rader A
Diagn Cytopathol; 2004 Apr; 30(4):235-9. PubMed ID: 15048956
[TBL] [Abstract][Full Text] [Related]
10. Use of p63 for distinction of glandular versus squamous lesions in cervicovaginal specimens.
Garcia MT; Acar BC; Jorda M; Gomez-Fernandez C; Ganjei-Azar P
Cancer; 2007 Feb; 111(1):54-7. PubMed ID: 17173320
[TBL] [Abstract][Full Text] [Related]
11. Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of bloody ThinPrep specimens with atypical squamous cells of undetermined significance interpretation: does pretreatment with acetic acid affect test performance?
Feng J; Husain M
Cancer; 2005 Dec; 105(6):452-6. PubMed ID: 16080178
[TBL] [Abstract][Full Text] [Related]
12. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study.
Schledermann D; Ejersbo D; Hoelund B
Cytopathology; 2004 Jun; 15(3):148-53. PubMed ID: 15165271
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the processing of bloody cervical specimens: glacial acetic acid and the ThinPrep Pap Test.
Haack LA; O'Brien D; Selvaggi SM
Diagn Cytopathol; 2006 Mar; 34(3):210-3. PubMed ID: 16470866
[TBL] [Abstract][Full Text] [Related]
15. Reprocessing unsatisfactory ThinPrep papanicolaou tests using a modified SurePath preparation technique.
Randolph ML; Wu HH; Crabtree WN
Cancer Cytopathol; 2014 May; 122(5):343-8. PubMed ID: 24940587
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the Thin Prep Imaging System in the detection of adenocarcinoma of the gynecologic system.
Friedlander MA; Rudomina D; Lin O
Cancer; 2008 Feb; 114(1):7-12. PubMed ID: 18085633
[TBL] [Abstract][Full Text] [Related]
17. Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
Colgan TJ; McLachlin CM; Cotterchio M; Howlett R; Seidenfeld AM; Mai VM
Cancer; 2004 Dec; 102(6):362-7. PubMed ID: 15481083
[TBL] [Abstract][Full Text] [Related]
18. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
19. Problems encountered with the Bethesda System: the University of Iowa experience.
Bottles K; Reiter RC; Steiner AL; Zaleski S; Bedrossian CW; Johnson SR
Obstet Gynecol; 1991 Sep; 78(3 Pt 1):410-4. PubMed ID: 1876375
[TBL] [Abstract][Full Text] [Related]
20. Not all unsatisfactory ThinPrep cervical Pap tests are unsatisfactory: Reprocessing improves the satisfactory and detection rates of ThinPrep cervical cytology.
AbdullGaffar B; Kamal MO
Diagn Cytopathol; 2010 Sep; 38(9):699-701. PubMed ID: 19950397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
